During 2014, Gilead's medicines helped more patients than ever before. Video Link Online Annual Review Read transcript
Exit Player
Loading the player ...


Gilead plays a central role in developing single tablet regimens – with one pill once a day, patients can take all of their medication in each dose.

Liver Diseases   

Our liver disease programs focus on expanding treatment options for chronic hepatitis B and C.

Hematology / Oncology   

Our scientists are applying new knowledge about how cancers grow and spread to potentially enhance and improve cancer therapy.


Our medicines aim to help patients with cardiovascular disease return to their daily activities, and we are exploring potential new indications.

Inflammation / Respiratory   

We research and develop treatments for serious respiratory conditions such as influenza, cystic fibrosis and other diseases of the lungs.

Other Therapies   

Gilead medicines treat severe fungal and parasitic infections, and address vision loss caused by degenerative eye diseases.

Accessing Treatment for Chronic Hepatitis C   

Gilead has made it a priority to help ensure worldwide access to its first-in-class treatment for hepatitis C. Learn more.

Careers and Culture   

Our greatest asset is our employees – not only their individual skills and expertise, but their personal commitment to our mission of making a difference in the lives of patients.